anti-human rhinovirus compounds (KU Leuven R&D/Catholic University of Leuven)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameanti-human rhinovirus compounds (KU Leuven R&D/Catholic University of Leuven)
Drug Alias NameRhinovirus Inhibitors (KU Leuven)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKu Leuven
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKu Leuven
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A